Ross Blundell

705 total citations
7 papers, 564 citations indexed

About

Ross Blundell is a scholar working on Pediatrics, Perinatology and Child Health, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Ross Blundell has authored 7 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 6 papers in Pharmaceutical Science and 2 papers in Molecular Biology. Recurrent topics in Ross Blundell's work include Drug Solubulity and Delivery Systems (6 papers), Pharmaceutical studies and practices (6 papers) and Enzyme Catalysis and Immobilization (2 papers). Ross Blundell is often cited by papers focused on Drug Solubulity and Delivery Systems (6 papers), Pharmaceutical studies and practices (6 papers) and Enzyme Catalysis and Immobilization (2 papers). Ross Blundell collaborates with scholars based in Denmark, France and Germany. Ross Blundell's co-authors include Eduardo Jule, Karen Kleberg, Annabel Igonin, Marilyn Calderone, Hywel D. Williams, Jan Vertommen, Hassan Benameur, Anette Müllertz, Philip Sassene and Colin W. Pouton and has published in prestigious journals such as Pharmaceutical Research, Journal of Pharmaceutical Sciences and Biochemical Society Transactions.

In The Last Decade

Ross Blundell

7 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ross Blundell Denmark 6 462 132 113 110 89 7 564
Marilyn Calderone France 8 477 1.0× 131 1.0× 118 1.0× 125 1.1× 91 1.0× 11 615
Annabel Igonin France 8 507 1.1× 138 1.0× 131 1.2× 132 1.2× 97 1.1× 9 650
Anne Larsen Denmark 7 447 1.0× 133 1.0× 88 0.8× 76 0.7× 92 1.0× 9 533
Mette U. Anby Australia 8 437 0.9× 123 0.9× 156 1.4× 94 0.9× 111 1.2× 9 554
Gunilla Hanisch Sweden 4 370 0.8× 134 1.0× 147 1.3× 103 0.9× 92 1.0× 4 507
Jef Stappaerts Belgium 12 301 0.7× 88 0.7× 96 0.8× 98 0.9× 111 1.2× 22 492
Stefania Beato Switzerland 9 473 1.0× 123 0.9× 224 2.0× 138 1.3× 98 1.1× 10 640
Sara Carlert Sweden 6 392 0.8× 99 0.8× 159 1.4× 66 0.6× 78 0.9× 12 512
M. Oth Belgium 7 400 0.9× 181 1.4× 74 0.7× 65 0.6× 69 0.8× 7 577
Sarah Clarysse Belgium 4 306 0.7× 90 0.7× 162 1.4× 72 0.7× 51 0.6× 6 406

Countries citing papers authored by Ross Blundell

Since Specialization
Citations

This map shows the geographic impact of Ross Blundell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Blundell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Blundell more than expected).

Fields of papers citing papers by Ross Blundell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Blundell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Blundell. The network helps show where Ross Blundell may publish in the future.

Co-authorship network of co-authors of Ross Blundell

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Blundell. A scholar is included among the top collaborators of Ross Blundell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Blundell. Ross Blundell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Sassene, Philip, Karen Kleberg, Hywel D. Williams, et al.. (2014). Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 6: Effects of Varying Pancreatin and Calcium Levels. The AAPS Journal. 16(6). 1344–1357. 55 indexed citations
2.
Williams, Hywel D., Philip Sassene, Karen Kleberg, et al.. (2014). Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 4: Proposing a New Lipid Formulation Performance Classification System. Journal of Pharmaceutical Sciences. 103(8). 2441–2455. 38 indexed citations
3.
Williams, Hywel D., Philip Sassene, Karen Kleberg, et al.. (2014). Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations. 5. Lipolysis of Representative Formulations by Gastric Lipase. Pharmaceutical Research. 32(4). 1279–1287. 54 indexed citations
5.
Williams, Hywel D., Philip Sassene, Karen Kleberg, et al.. (2012). Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 1: Method Parameterization and Comparison of In Vitro Digestion Profiles Across a Range of Representative Formulations. Journal of Pharmaceutical Sciences. 101(9). 3360–3380. 219 indexed citations
7.
Waring, R. H., S. C. Mitchell, Ross Blundell, & Richard L. Smith. (1986). Novel aspects of the metabolism of cimetidine in the guinea pig. Biochemical Society Transactions. 14(1). 98–99. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026